These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26969347)

  • 1. (18)F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease.
    Ruhlmann V; Poeppel TD; Brandt AS; Grüneisen J; Ruhlmann M; Theysohn JM; Forsting M; Bockisch A; Umutlu L
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1646-52. PubMed ID: 26969347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease activity and vascular involvement in retroperitoneal fibrosis: first experience with fully integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging compared to clinical and laboratory parameters.
    Thuermel K; Einspieler I; Wolfram S; Moog P; Meier R; Schwaiger M; Heemann U
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):146-154. PubMed ID: 27974103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT and contrast-enhanced CT in a one-stop diagnostic procedure: a better strategy for management of patients suffering from retroperitoneal fibrosis?
    Guignard R; Simukoniene M; Garibotto V; Ratib O
    Clin Nucl Med; 2012 May; 37(5):453-9. PubMed ID: 22475894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of (18)F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis.
    Moroni G; Castellani M; Balzani A; Dore R; Bonelli N; Longhi S; Martinelli I; Messa P; Gerundini P
    Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1635-42. PubMed ID: 22801728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
    Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
    Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
    AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study.
    Einspieler I; Thürmel K; Pyka T; Eiber M; Wolfram S; Moog P; Reeps C; Essler M
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1012-24. PubMed ID: 25876704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Fernando A; Pattison J; Horsfield C; D'Cruz D; Cook G; O'Brien T
    Eur Urol; 2017 Jun; 71(6):926-933. PubMed ID: 27876167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
    Jansen I; Hendriksz TR; Han SH; Huiskes AW; van Bommel EF
    Eur J Intern Med; 2010 Jun; 21(3):216-21. PubMed ID: 20493425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: Correlation between glucose metabolism and apparent diffusion coefficient.
    Kong E; Chun KA; Cho IH
    PLoS One; 2017; 12(7):e0180184. PubMed ID: 28672016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new method for apparent diffusion coefficient measurement using sequential (18)F-FDG PET and MRI: correlation with histological grade of invasive ductal carcinoma of the breast.
    Byun BH; Noh WC; Lim I; Lee SS; Cho AR; Park JA; Kim KM; Kim HA; Kim EK; Kim BI; Choi CW; Lim SM
    Ann Nucl Med; 2013 Oct; 27(8):720-8. PubMed ID: 23700260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
    Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
    J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
    Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
    Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performances of FDG-PET/CT and diffusion-weighted imaging indices for differentiating benign pheochromocytoma from other benign adrenal tumors.
    Nakajo M; Nakajo M; Fukukura Y; Jinguji M; Shindo T; Nakabeppu Y; Kamimura K; Yoneyama T; Takumi K; Yoshiura T
    Abdom Imaging; 2015 Aug; 40(6):1655-65. PubMed ID: 25382022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse.
    Morin G; Mageau A; Benali K; Bertinchamp R; Piekarski E; Raimbourg Q; Alexandra JF; Goulenok T; van Gysel D; Papo T; Sacre K
    Eur J Intern Med; 2019 Apr; 62():67-71. PubMed ID: 30711361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does positron emission tomography data acquisition impact simultaneous diffusion-weighted imaging in a whole-body PET/MRI system?
    Buchbender C; Hartung-Knemeyer V; Heusch P; Heusner TA; Beiderwellen K; Wittsack HJ; Kühl H; Forsting M; Bockisch A; Antoch G; Lanzman RS
    Eur J Radiol; 2013 Feb; 82(2):380-4. PubMed ID: 23238361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hybrid molecular imaging in retroperitoneal fibrosis: a systematic review.
    Grozdic Milojevic IT; Milojevic B; Sobic-Saranovic DP; Artiko VM
    Rheumatol Int; 2018 Feb; 38(2):179-187. PubMed ID: 28840309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.